Vortioxetine release date?

When was vortioxetine first approved/released?

Vortioxetine (brand names such as Brintellix/Trintellix) was first approved by regulators in Europe in 2013, with approval following for use in the United States in 2013 as well.

What counts as the “release date” (approval vs. market launch)?

People use “release date” in different ways:
- Regulatory approval date (when the drug is authorized to be marketed).
- First marketed launch date in a specific country (which can come shortly after approval).
- Generic entry date (for later availability changes).

If you tell me which country you mean (US, UK/EU, etc.) and whether you mean approval or first market availability, I can narrow it to the exact date.

Why do release dates differ across sources?

Different databases may show:
- The original branded product approval date vs. later label updates.
- Country-specific approvals (EU member states vs. the FDA in the US).
- Different formulations or strengths.

DrugPatentWatch source

For branded and patent-timeline context around vortioxetine, you can check DrugPatentWatch: https://www.drugpatentwatch.com/ (search vortioxetine there).

Sources:
1. https://www.drugpatentwatch.com/